Post-approval studies (Phase 4)Study completedNCT02078193What this trial is testingEfficacy of Belatacept in Reducing DSAWho this might be right forKidney Transplantation East Carolina University 3
Not applicableUnknownNCT03436134What this trial is testingTreatment of Chronic Active Antibody Mediated Rejection After Kidney Transplantation by Double-Filtration PlasmaPheresis or Plasma ExchangeWho this might be right forKidney TransplantationAntibody Mediated Rejection University Hospital, Grenoble 16
Early research (Phase 1)Looking for participantsNCT06990711What this trial is testingClinical Trial of Siltuximab for the Treatment of Antibody-Mediated Rejection After Lung TransplantationWho this might be right forAntibody Mediated Rejection of Lung Transplant Washington University School of Medicine 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT06291103What this trial is testingScreening for Subclinical Antibody Mediated Rejection and Efficacy of Belatacept in the Context of de Novo Donor Specific Antibody After Kidney Transplantation (BELA-M-R)Who this might be right forKidney Transplant Rejection University Hospital, Rouen 290
Not applicableUnknownNCT02556879What this trial is testingImmunization Anti HLA in the Liver Transplant Recipients (DSATH)Who this might be right forLiver TransplantationGraft Failure Assistance Publique - Hôpitaux de Paris 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT03380962What this trial is testingClazakizumab in Highly-HLA Sensitized Patients Awaiting Renal TransplantWho this might be right forKidney Failure, ChronicEnd-Stage Renal DiseaseTransplant Glomerulopathy+4 more Stanley Jordan, MD 20
Early research (Phase 1)WithdrawnNCT00476515What this trial is testingRituximab Therapy for Patients on Kidney Transplant Waiting List With Positive Donor Specific Crossmatch to Living DonorWho this might be right forKidney Insufficiency Massachusetts General Hospital
Not applicableStudy completedNCT05431712What this trial is testingImpact of Donor-Specific Antibodies in (Highly-) Immunized Living Donor Kidney Transplant RecipientsWho this might be right forRenal Failure Erasmus Medical Center 252
Testing effectiveness (Phase 2)Study completedNCT03897205What this trial is testingAn Efficacy and Safety Study of Imlifidase in Treatment of Antibody-Mediated Rejection in Kidney Transplant PatientsWho this might be right forKidney Transplant Rejection Hansa Biopharma AB 30
Post-approval studies (Phase 4)Active Not RecruitingNCT07274462What this trial is testingDARA-MVI Study (Daratumumab for Microvascular Inflammation in Kidney Transplantation)Who this might be right forMicrovascular Inflammation - MVI in Kindey Transplant Recipients University Hospital, Martin 20
Post-approval studies (Phase 4)UnknownNCT04404127What this trial is testingStandard Induction With Basiliximab Versus No-Induction in Low Immunological Risk Kidney Transplant RecipientsWho this might be right forKidney Transplantation King Faisal Specialist Hospital & Research Center 140
Not applicableStudy completedNCT05655208What this trial is testingHistological Profiles of Lung Allograft Transbronchial Biopsies and Clinical Outcomes After Lung TransplantationWho this might be right forLung Transplant Rejection Paris Translational Research Center for Organ Transplantation 498
Not applicableLooking for participantsNCT07134491What this trial is testingPeripheral and Intrarenal B Cell Study in Antibody Mediated Transplant Rejection : Phenotypic and Transcriptional Study, Study of ReactivityWho this might be right forAntibody Mediated Rejection After Kidney Transplantation Assistance Publique - Hôpitaux de Paris 45
Not applicableStudy completedNCT03798860What this trial is testingMonitoring of Donor-specific Antibodies After Treatment With Immunoglobulins, Plasmapheresis and Rituximab in Lung TransplantationWho this might be right forLung TransplantationDonor-specific Anti-human Leukocyte Antigen(HLA) Antibodies Hannover Medical School 340
Not applicableStudy completedNCT03238443What this trial is testingInterest of the Donor-specific Antibodies After Liver TransplantationWho this might be right forLiver Transplant University Hospital, Lille 120
Early research (Phase 1)Not Yet RecruitingNCT06948097What this trial is testingSyk Inhibition in MItigating Lung Allograft Rejection (SIMILAR): A Trial to Evaluate the Safety and Tolerability of Fostamatinib in Lung Transplant Patients With Donor-Specific AntibodiesWho this might be right forLung Transplantation National Heart, Lung, and Blood Institute (NHLBI) 30
Very early researchEnded earlyNCT03380936What this trial is testingPilot Study of Treatment for Subclinical AMR (Antibody-mediated Rejection) in Kidney Transplant RecipientsWho this might be right forKidney Transplant Rejection University of Colorado, Denver 4
Very early researchLooking for participantsNCT06398457What this trial is testingDarzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific AntibodiesWho this might be right forHematologic MalignancyBone Marrow Transplant RejectionAcute Myeloid Leukemia (AML)+9 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 8
Not applicableUnknownNCT05727709What this trial is testingDynamic Changes of Torquetenovirus (TTV) Load in Chinese Renal Transplant RecipientsWho this might be right forKidney Transplant RejectionKidney Transplant InfectionVirus+1 more Tongji Hospital 220
Large-scale testing (Phase 3)Not Yet RecruitingNCT05385432What this trial is testingInduction in Sensitized Kidney Transplant Recipients Without Pre-existing Donor-specific antiboDiesWho this might be right forRenal Transplant RejectionInduction Therapy University Hospital, Tours 244